empagliflozin vs zonisamide
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of empagliflozin and zonisamide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Table 4 Clinically Relevant Interactions with SYNJARDY or SYNJARDY XR Carbonic Anhydrase Inhibitors Clinical Impact Topiramate or other carbonic anhydrase inhibitors (e.g., zonisamide, acetazolamide or dichlorphenamide) frequently causes a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis.
Jardiance
Zonegran
No summary available.
Zonisamide is a medicine used with other medicines to treat partial seizures in adults with epilepsy. It belongs to a class of drugs called anticonvulsants.
Information not available.
Zonisamide is used to treat partial seizures in adults who have epilepsy. Epilepsy is a brain disorder that causes repeated seizures. This medicine is used along with other seizure medicines to help control your seizures.
Information not available.
Zonisamide works by slowing down the electrical signals in the brain that cause seizures. It is thought to stabilize nerve cell membranes, which reduces the chance of seizures. It may also affect certain chemicals in the brain.
- • Urinary tract infection
- • Yeast infection (in women)
- • Diarrhea
- • Nausea
- • Vomiting
- • Feeling sleepy
- • Loss of appetite
- • Dizziness
- • Problems with coordination
- • Feeling agitated or irritable
- Diabetic Ketoacidosis 3,773
- Nausea 3,212
- Blood Glucose Increased 3,043
- Diarrhoea 2,806
- Weight Decreased 2,749
- Seizure 1,574
- Fatigue 697
- Somnolence 645
- Convulsion 623
- Dizziness 558
No specific warnings noted.
If you are allergic to sulfonamide medicines, you should not take zonisamide. Using zonisamide with other medicines that also inhibit carbonic anhydrase (like topiramate) can increase the risk of metabolic acidosis, kidney stones, and high ammonia levels in the blood.
No pregnancy information available.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if zonisamide will harm your unborn baby. Talk to your doctor about the risks and benefits of taking zonisamide during pregnancy. It is also not known if zonisamide passes into breast milk, so talk to your doctor before breastfeeding.
Also Compare, Nearby Drugs
Compare empagliflozin with
How to Read This empagliflozin vs zonisamide Comparison
empagliflozin is classified in the SGLT2 Inhibitor drug class, while zonisamide sits within the Anticonvulsant (Sulfonamide) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, empagliflozin has 15,583 submissions while zonisamide has 4,097. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to zonisamide can cause a buildup of acid in your blood by lowering bicarbonate levels. taking it with this medicine may increase the risk of this chemical imbalance.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for empagliflozin or zonisamide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.